Search Patents
  • PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIGEROL
    Publication number: 20140039043
    Abstract: The present invention relates to the use of cannabigerol (CBG) type compounds and derivatives thereof in the treatment of mood disorders.
    Type: Application
    Filed: April 24, 2013
    Publication date: February 6, 2014
    Applicant: GW Pharma Limited
    Inventor: GW Pharma Limited
  • Use for pharmaceutical composition
    Publication number: 20060135599
    Abstract: The invention relates to the use of one or more cannabinoids in the treatment of neuropathic or chronic pain.
    Type: Application
    Filed: November 3, 2003
    Publication date: June 22, 2006
    Applicant: GW Pharma Limited
    Inventors: Catherine Symonds, Jonathan Berman
  • Inhibition of Tumour Cell Migration
    Publication number: 20080262099
    Abstract: The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.
    Type: Application
    Filed: September 30, 2005
    Publication date: October 23, 2008
    Applicant: GW Pharma Limited
    Inventors: Brian Whittle, Daniela Parolaro
  • INHIBITION OF TUMOUR CELL MIGRATION
    Publication number: 20190255011
    Abstract: The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.
    Type: Application
    Filed: September 26, 2018
    Publication date: August 22, 2019
    Applicant: GW Pharma Limited
    Inventors: Brian Anthony WHITTLE, Daniela PAROLARO
  • PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIGEROL
    Publication number: 20080031977
    Abstract: The present invention relates to the use of cannabigerol (CBG) type compounds and derivatives thereof in the treatment of mood disorders.
    Type: Application
    Filed: June 8, 2007
    Publication date: February 7, 2008
    Applicant: GW Pharma Limited
    Inventors: Richard Musty, Richard Deyo
  • Pharmaceutical compositions comprising cannabigerol
    Patent number: 8481085
    Abstract: The present invention relates to the use of cannabigerol (CBG) type compounds and derivatives thereof in the treatment of mood disorders.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: July 9, 2013
    Assignee: GW Pharma Limited
    Inventors: Richard Musty, Richard Deyo
  • INHIBITION OF TUMOUR CELL MIGRATION
    Publication number: 20120225136
    Abstract: The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.
    Type: Application
    Filed: April 5, 2012
    Publication date: September 6, 2012
    Applicant: GW Pharma Limited
    Inventors: Brian Whittle, Daniela Parolaro
  • SYNERGISTIC THERAPIES OF CANNABIDIOL WITH HYPOTHERMIA FOR NEUROPROTECTION
    Publication number: 20150328171
    Abstract: The present invention relates to the combination of the phytocannabinoid cannabidiol with therapeutic hypothermia for use in the treatment of neuroprotection or astroprotection.
    Type: Application
    Filed: June 10, 2013
    Publication date: November 19, 2015
    Applicant: GW Pharma Limited
    Inventors: Jose Martinez-Orgado, Geoffrey Guy
  • Pharmaceutical compositions comprising cannabichromene type compounds
    Patent number: 8470874
    Abstract: The invention relates to the use of cannabichromene type compounds and derivatives thereof in the treatment of mood disorders.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: June 25, 2013
    Assignee: GW Pharma Limited
    Inventors: Richard E. Musty, Richard Deyo
  • Pharmaceutical formulations
    Patent number: 6730330
    Abstract: The invention relates to pharmaceutical formulations for use in the administration of medicaments, in particular lipophilic medicaments, via mucosal surfaces.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: May 4, 2004
    Assignee: GW Pharma Limited
    Inventors: Brian A. Whittle, Geoffrey W. Guy
  • Methods of purifying cannabinoids from plant material
    Publication number: 20050266108
    Abstract: The invention relates to methods of preparing cannabinoids in substantially pure form starting from plant material. Also described are substantially pure preparations of various cannabinoids and cannabinoid acids, and also extracts enriched in cannabinoids and cannabinoid acids.
    Type: Application
    Filed: September 23, 2003
    Publication date: December 1, 2005
    Applicant: Gw Pharma Limited
    Inventors: Ian Flockhart, Gary Wheatley, Su Dring, Leslie Archer
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN
    Publication number: 20110230549
    Abstract: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.
    Type: Application
    Filed: April 26, 2011
    Publication date: September 22, 2011
    Applicant: GW Pharma Limited
    Inventors: Geoffrey Guy, Philip Robson
  • Pharmaceutical compositions for the treatment of pain
    Publication number: 20060247304
    Abstract: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 2, 2006
    Applicant: GW Pharma Limited
    Inventors: Geoffrey Guy, Philip Robson
  • Use for Cannabinoid
    Publication number: 20090306221
    Abstract: The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in 0 the treatment of diseases and conditions benefiting from inverse agonism of the CB1 and/or the CB2 cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof.
    Type: Application
    Filed: May 31, 2007
    Publication date: December 10, 2009
    Applicant: GW PHARMA LIMITED
    Inventors: Geoffrey Guy, Roger Pertwee, Adele Thomas
  • Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour
    Patent number: 10758514
    Abstract: The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: September 1, 2020
    Assignee: GW Pharma Limited
    Inventors: Wai Liu, Katherine Scott, Angus Dalgleish, Marnie Duncan, Colin Stott
  • Method for the treatment of constipation
    Patent number: 8771760
    Abstract: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: July 8, 2014
    Assignee: GW Pharma Limited
    Inventors: Geoffrey Guy, Philip Robson
  • USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIOSENSITIVITY IN THE TREATMENT OF A BRAIN TUMOUR
    Publication number: 20190099398
    Abstract: The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.
    Type: Application
    Filed: May 2, 2018
    Publication date: April 4, 2019
    Applicant: GW Pharma Limited
    Inventors: Wai LIU, Katherine SCOTT, Angus DALGLEISH, Marnie Duncan, Colin Stott
  • Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
    Patent number: 9675579
    Abstract: The present invention relates to the use of tetrahydrocannabivarin (THCV) in the treatment of nausea and vomiting. Preferably the THCV is isolated and/or purified from cannabis plant extracts. Preferably the nausea and/or vomiting is caused by the effects of a medication such as a chemotherapeutic agent.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: June 13, 2017
    Assignee: GW Pharma Limited
    Inventors: Erin Rock, Linda Parker, Marnie Duncan, Colin Stott
  • Secure container for holding liquid medicaments
    Patent number: D559396
    Type: Grant
    Filed: January 30, 2006
    Date of Patent: January 8, 2008
    Assignee: GW Pharma Limited
    Inventor: Rajiv B. Dave
  • Hand-held electronic device
    Patent number: D562316
    Type: Grant
    Filed: January 30, 2006
    Date of Patent: February 19, 2008
    Assignee: GW Pharma Limited
    Inventor: Rajiv B. Dave
Narrow Results

Filter by US Classification